Virucidal Activity of World Health Organization-Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses.
dc.contributor.author | Siddharta, Anindya | |
dc.contributor.author | Pfaender, Stephanie | |
dc.contributor.author | Vielle, Nathalie Jane | |
dc.contributor.author | Dijkman, Ronald | |
dc.contributor.author | Friesland, Martina | |
dc.contributor.author | Becker, Britta | |
dc.contributor.author | Yang, Jaewon | |
dc.contributor.author | Engelmann, Michael | |
dc.contributor.author | Todt, Daniel | |
dc.contributor.author | Windisch, Marc P | |
dc.contributor.author | Brill, Florian H | |
dc.contributor.author | Steinmann, Joerg | |
dc.contributor.author | Steinmann, Jochen | |
dc.contributor.author | Becker, Stephan | |
dc.contributor.author | Alves, Marco P | |
dc.contributor.author | Pietschmann, Thomas | |
dc.contributor.author | Eickmann, Markus | |
dc.contributor.author | Thiel, Volker | |
dc.contributor.author | Steinmann, Eike | |
dc.date.accessioned | 2017-06-22T09:40:09Z | |
dc.date.available | 2017-06-22T09:40:09Z | |
dc.date.issued | 2017-03-15 | |
dc.identifier.citation | Virucidal Activity of World Health Organization-Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses. 2017, 215 (6):902-906 J. Infect. Dis. | en |
dc.identifier.issn | 1537-6613 | |
dc.identifier.pmid | 28453839 | |
dc.identifier.doi | 10.1093/infdis/jix046 | |
dc.identifier.uri | http://hdl.handle.net/10033/620973 | |
dc.description.abstract | The World Health Organization (WHO) published 2 alcohol-based formulations to be used in healthcare settings and for outbreak-associated infections, but inactivation efficacies of these products have not been determined against (re-)emerging viruses. In this study, we evaluated the virucidal activity of these WHO products in a comparative analysis. Zika virus (ZIKV), Ebola virus (EBOV), severe acute respiratory syndrome coronavirus (SARS-CoV), and Middle East respiratory syndrome coronavirus (MERS-CoV) as (re-)emerging viral pathogens and other enveloped viruses could be efficiently inactivated by both WHO formulations, implicating their use in healthcare systems and viral outbreak situations. | |
dc.language.iso | en | en |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/4.0/ | * |
dc.title | Virucidal Activity of World Health Organization-Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses. | en |
dc.type | Article | en |
dc.contributor.department | TWINCORE, Zentrum für experimentelle und klinische Infektionsforschung gmbH, Feodor-Lynen Str. 7, 30625 Hannover, Germany. | en |
dc.identifier.journal | The Journal of infectious diseases | en |
refterms.dateFOA | 2018-06-12T16:52:37Z | |
html.description.abstract | The World Health Organization (WHO) published 2 alcohol-based formulations to be used in healthcare settings and for outbreak-associated infections, but inactivation efficacies of these products have not been determined against (re-)emerging viruses. In this study, we evaluated the virucidal activity of these WHO products in a comparative analysis. Zika virus (ZIKV), Ebola virus (EBOV), severe acute respiratory syndrome coronavirus (SARS-CoV), and Middle East respiratory syndrome coronavirus (MERS-CoV) as (re-)emerging viral pathogens and other enveloped viruses could be efficiently inactivated by both WHO formulations, implicating their use in healthcare systems and viral outbreak situations. |